Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, Jawed Fareed, John M. Dye, Prakasha Kempaiah

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)203-212
Number of pages10
JournalInternational Journal of Biological Macromolecules
Volume183
DOIs
StatePublished - Jul 31 2021

Keywords

  • Anticoagulant
  • COVID-19
  • Heparin
  • Lipid-based formulations
  • SARS-CoV2
  • Spike protein
  • Sulfated polysaccharide
  • Topical delivery
  • Transmission-blocking

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Economics and Econometrics
  • Energy(all)

Fingerprint

Dive into the research topics of 'Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy'. Together they form a unique fingerprint.

Cite this